Invea Therapeutics, Inc filed a Form S-1 registration statement for an initial public offering on 2025-12-15. It has amended it 3 times. It asked for the registration statement to be withdrawn on 2026-03-06. Each fact below is quoted from the filing named with it.
What the filings say
Listing
We have applied to list our shares of common stock on the Nasdaq Capital Market, or Nasdaq, under the symbol “INAI.” It is a condition to the closing of this offering that our shares of common stock shall have been approved for listing on Nasdaq.From the S-1/A filed 2026-01-27
Price range
This is a firm commitment initial public offering of 3,200,000 shares of common stock, par value $0.0001 per share, of Invea Therapeutics, Inc. The anticipated initial public offering price will be between $10.00 and $12.00 per share of common stock.From the S-1/A filed 2026-01-27
Use of proceeds
We currently intend to use the net proceeds from this offering, together with our existing cash as follows:From the S-1/A filed 2026-01-27
Net loss or income
Our net losses were $2.9 million and $5.4 million for the nine months periods ended September 30, 2025 and 2024, respectively, and $6.3 million and $9.9 million for the years ended December 31, 2024 and 2023, respectively.From the S-1/A filed 2026-01-27
Withdrawal
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “ Securities Act ”), Invea Therapeutics, Inc. (the “ Registrant ”) hereby respectfully requests that the U.S. Securities and Exchange Commission (the “ Commission ”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Registration Statement on Form S-1 (File No. 333-292131) together with all exhibits and amendments thereto (collectively, the “ Registration Statement ”) initially filed with the Commission on December 15, 2025 and declared effective by the Commission on January 30, 2026 at 2:00 p.m.From the RW filed 2026-03-06
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-12-15 | Registration statement filed | S-1 |
| 2026-01-07 | Registration statement amended | S-1/A |
| 2026-01-23 | Registration statement amended | S-1/A |
| 2026-01-27 | Registration statement amended | S-1/A |
| 2026-03-06 | Request to withdraw a registration (Form S-1) | RW |
Tools for this story
Each opens in a new tab, filled in for Invea Therapeutics, Inc. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.